Walmart in partnership to provide domestic antibiotics
Walmart is teaming up with a U.S.-based antibiotics manufacturer and a pharmaceutical wholesaler.
The discount giant is collaborating with USAntibiotics, the nation’s lone remaining manufacturer of amoxicillin and amoxicillin clavulanate, and wholesaler ClarusOne Sourcing Services to provide domestically manufactured antibiotics made by USAntibiotics in the U.S.
The collaboration will see USAntibiotics supply millions of doses of amoxicillin directly to Walmart pharmacies, as well as to healthcare services provider McKesson for distribution to pharmacies, health systems and healthcare providers nationwide.
This collaboration builds on Walmart’s pledge to invest an additional $350 billion in products made, grown, or assembled in the U.S. by 2030. USAntibiotics says its 394,000-sq.-ft. production facility in Bristol, Tenn., has the capacity to produce enough amoxicillin products to meet 100% of the nation’s demand for these medications.
[READ MORE: Walmart makes major commitment to U.S. manufacturing]
“We are thrilled to work with Walmart and McKesson to bring domestically manufactured antibiotics directly to American families,” said Patrick Cashman, president of USAntibiotics. “We extend our deepest gratitude to Walmart and McKesson for their leadership in supporting U.S. manufacturing of critical generic medicines. This collaboration represents more than a business relationship – it's a commitment to America’s health security.”
Walmart opens high-tech centralized prescription processing facility
In May 2025, Walmart opened a 102,000-sq.-ft. facility in Frederick, Md. designed to fulfill up to 100,000 prescriptions a day, supporting more than 700 stores across 16 states and Washington, D.C.
This facility uses advanced pharmacy automation with dynamic weighting systems, robotic carriers and a conveyance route designed to streamline every step of prescription fulfillment, from pill counting and labeling to capping and sorting. It employs pharmacists, pharmacy technicians and patient safety associates to provide expert oversight.
With this launch, Walmart continues to expand its central fill operations to meet growing demand for pharmacy services including online shopping with fast delivery of prescriptions, as well as pharmacist-provided clinical services including immunizations and testing and treatment for strep throat, flu and COVID.
Two more pharmacy central fill facilities are in development — one in Phoenix and another in Republic, Mo. — and are expected to open in 2026.
Based in Bentonville, Ark., Walmart operates 10,750 stores and numerous e-commerce websites in 19 countries.
